QuidelOrtho Beats Q3 Earnings Estimates but Lowers Full-Year Revenue Guidance
Key Facts
QuidelOrtho reported adjusted earnings per share of $0.31 for the third quarter ended September 27, 2026, beating analyst estimates despite a 12% revenue decline to $619 million. According to a statement on PR Newswire, persistent challenges in the Chinese market led the company to lower its full-year 2026 revenue guidance to $2.53 billion.
The company launched a cost transformation program targeting over $80 million in annual savings by 2027, anticipating one-time restructuring charges of $30 million to $35 million in the fourth quarter of 2026. Regarding equity performance, QDEL closed at $14.03 on November 2, 2026, after trading between a session low of $13.09 and a high of $14.28.
Latest Updates · 3
- Notable·
Update: QuidelOrtho reported adjusted earnings per share (EPS) of $0.31 for the third quarter of 2026. These results come as the company continues to execute its financial transformation strategy to address operational pressures.
- Notable·
Update: QuidelOrtho announced the elimination of the Chief Operations Officer role as part of its cost transformation and restructuring program. This organizational change aligns with the company's efforts to streamline operations and achieve its previously stated annual savings targets.
- Notable·
Update: QuidelOrtho recorded a GAAP net loss of $54 million for the third quarter, while adjusted diluted earnings per share stood at $0.31. The company also reported a 27% decline in Point of Care revenue, which it attributed to a softer respiratory season.